Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 6, 2012, Pages 724-725

  Tamura, S ^a   Warabi, Y ^a   Matsubara, S ^a  

^a Tokyo Metropolitan Neurological ^*  (Japan)

Author keywords

adverse effect; combination therapy; drug herb interaction; herbal medicine; interferon beta; liver toxicity; melilot; multiple sclerosis; review; sweet clover

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA1A INTERFERON; COUMARIN; INTERFERON BETA SERINE; MELILOTUS EXTRACT; XANTHOPHYLL;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER DYSFUNCTION; LIVER TOXICITY; MULTIPLE SCLEROSIS; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COUMARINS; DRUG COMBINATIONS; DRUG-INDUCED LIVER INJURY; FEMALE; HERB-DRUG INTERACTIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MULTIPLE SCLEROSIS; RESINS, PLANT; RUTIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84868338824     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2012.01350.x     Document Type: Article

References (9)

1. Yuce B, Gulberg V, Diebold J, Gerbes AL,. Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion, 2006; 73: 167-170.
2. Yoshida EM, Rasmussen SL, Steinbrecher UP, et al. Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology, 2001; 56: 1416.
3. Adam BS, Pentz R, Siegers CP, Strubelt O, Tegtmeier M,. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. Phytomedicine, 2005; 12: 52-61.
4. Ruhl CE, Everhart JE,. Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology, 2003; 124: 1821-1829.
5. Tremlett HL, Yoshida EM, Oger J,. Liver injury associated with the beta-interferons for MS: a comparison between the three products. Neurology, 2004; 62: 628-631.
6. Izzo AA, Ernst E,. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs, 2001; 61: 2163-2175.
7. Negishi M, Lindberg R, Burkhart B, Ichikawa T, Honkakoski P, Lang M,. Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450 15alpha as coumarin 7-hydroxylase. Biochemistry, 1989; 28: 4169-4172.
8. Born SL, Caudill D, Fliter KL, Purdon MP,. Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab Dispos, 2002; 30: 483-487.
9. Born SL, Caudill D, Smith BJ, Lehman-McKeeman LD,. In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity. Toxicol Sci, 2000; 58: 23-31.